Join AlphaMaven

The Home Of Alternative Investments

Register For Free Learn More Create Investment Listing

Most Visited Alternative Investment Industry Website. Over 50,000 visitors per month

Alternative Investment Posts

Andrea Alms Video:  Money In Motion 157 - Disruption In The Gene Cell Therapy Market
Private Equity BrookDell Partners Views: 1

Andrea Alms Video: Money in Motion 157 - Disruption in the Gene Cell Therapy Market

TRANSCRIPT:   Hello, my name is Andrea Alms. I'm a technology investor and financial manager and this is your money in motion. In the news selling gene therapy reckoning industry giants retreat as safety concerns and regulatory shifts reshape the landscape. Vertex, Pfizer, Takeda are leaving the AAV gene medicine research. The manufacturing economics are challenging a 2 to $3 million per dose an


Member Posts:

Most popular| Most recent
Engine Capital, LP - AlphaMaven Performance Report
Hedge Fund Engine Capital, LP #Investment Update
QCAM FX Bias - AlphaMaven Performance Report
Hedge Fund QCAM FX BIAS #Investment Update
Teton Concentrated Strategy - AlphaMaven Performance Report
Hedge Fund Teton Concentrated Strategy #Investment Update
The Spitfire Fund L.P. - AlphaMaven Performance Report
Hedge Fund The Spitfire Fund L.P. #Investment Update
Ayaltis AG's Areca SICAV SIF - Adilya Fund Class C USD - AlphaMaven Performance Report
Hedge Fund Areca SICAV SIF - Adilya Fund Class C USD #Investment Update
Prime Meridian NPL, LLC Posts Its November 2024 Returns
Hedge Fund Prime Meridian NPL, LLC #Presentation #Investment Update
Prime Meridian NPL, LLC Posts Its October 2024 Returns
Hedge Fund Prime Meridian NPL, LLC #Presentation #Investment Update
Armington Capital Trading Program - AlphaMaven Performance Report
Managed Futures Armington Capital Trading Program #Investment Update
M&R Livestock Trading Program - AlphaMaven Performance Report
Managed Futures Livestock Trading Program #Investment Update
Opus Futures Macro Monitor Program - AlphaMaven Performance Report
Managed Futures Opus Futures Macro Monitor Program #Investment Update
Ridgedale MSP Partner Series - AlphaMaven Performance Report
Hedge Fund Ridgedale MSP Partner Series #Investment Update
Niederhoffer Smart Alpha Program - AlphaMaven Performance Report
Managed Futures R.G. Niederhoffer Smart Alpha Program #Investment Update
Ridgedale MSP 14 Vol - AlphaMaven Performance Report
Hedge Fund Ridgedale MSP 14 Vol #Investment Update
Teton Long Only Strategy - AlphaMaven Performance Report
Hedge Fund Teton Long Only Strategy #Investment Update
Ayaltis Areca SICAV-SIF - Alethea Fund Class A USD - AlphaMaven Performance Report
Hedge Fund Areca SICAV SIF - Alethea Fund Class A USD #Investment Update
Areca SICAV SIF - Alant Fund Class A USD - AlphaMaven Performance Report
Hedge Fund Areca SICAV SIF - Alant Fund Class A USD #Investment Update
Ditsch Agricultural Trading Program - AlphaMaven Performance Report
Managed Futures Ditsch Trading Agricultural Trading Program #Investment Update
Ridgedale MSP 7 Vol Note - AlphaMaven Performance Report
Hedge Fund Ridgedale MSP 7 Vol Note #Investment Update
R.G. Niederhoffer Macro Diversified Program - AlphaMaven Performance Report
Managed Futures R.G. Niederhoffer Macro Diversified Program #Investment Update
Davis Commodities Managed Futures Trading Program - AlphaMaven Performance Report
Managed Futures Davis Commodities - Managed Futures Trading Program #Investment Update
CREATE A FREE MEMBERSHIP
View Member Posts Listings
SPONSORED BY
Be Seen - Advertise With Us
Click to Discuss
FEATURED MEMBER POSTS
Exome Worldwide Healthcare Partners Posts Its April 2025 Performance
- posted by: Worldwide Healthcare Partners
Exome's Emerging Markets Healthcare Strategy Posts Its April 2025 Results
- posted by: Emerging Markets Healthcare Partners Strategy
Andrea Alms Video:  Money In Motion 159 - Bitcoin Energy Mining
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 160 - Pharma Q1 2025 Revenue Decline
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 158 - Micro Carrier Market Update
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 156 - Measles Vaccine Market
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 155 - Healthcare Professional Training Market
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 157 - Disruption In The Gene Cell Therapy Market
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 154 - Cell Therapy Manufacturing Market
- posted by: BrookDell Partners
Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates

Subscribe to our FREE DAILY newsletter

Please Select Industry Primary Role*
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
Sign Up Now
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.